Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. metabolism analysis
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Metabolism Analysis Articles & Analysis

5 news found

Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research   

Creative Proteomics Introduces Central Carbon Metabolism Analysis Service to Accelerate Metabolic Research  

Creative Proteomics, a leader in proteomics and metabolomics services, has officially launched its innovative Central Carbon Metabolism (CCM) Analysis Service, designed to transform the study of cellular energy dynamics and metabolic pathways in both health and disease. ...

ByCreative Proteomics


CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

CD BioGlyco, a biotechnology company that provides multi-omics analysis of cancer cell glycolysis including genomics, proteomics, metabolomics and metabolic fluxomics, now offers analysis of glycolytic enzymes in cancer cells, enabling thorough understanding of cancer cell glycolysis pathways. ...

ByCD BioGlyco.


Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological drugs in vivo. The application of LC-MS/MS in biotechnological drug metabolite identification is a popular research topic. ...

ByCreative Proteomics


Neurona Therapeutics Presents Preclinical Data at the American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001, Being Evaluated in a Phase 1/2 Clinical Trial for Chronic Focal Epilepsy

Neurona Therapeutics Presents Preclinical Data at the American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001, Being Evaluated in a Phase 1/2 Clinical Trial for Chronic Focal Epilepsy

Of translational relevance as a potential biomarker of seizure reduction, non-invasive 1H MRS analysis revealed a metabolic signature of the epileptic hippocampus that was corrected to normal, non-epileptic levels following NRTX-1001 administration. ...

ByNeurona Therapeutics


Creative Enzymes Upgrades Metabolic Flux Analysis to Accelerate Your Project

Creative Enzymes Upgrades Metabolic Flux Analysis to Accelerate Your Project

Since the beginning of biocatalysis development, metabolic flux analysis (MFA) has been a cornerstone of pathway engineering. ...

ByCreative Enzymes

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT